S Dell-Kuster
Impact of loss of high-molecular-weight von Willebrand factor multimers on blood loss after aortic valve replacement
Bolliger D, Dell-Kuster S, Seeberger M, Tanaka K, Gregor M, Zenklusen U, Tsakiris D, Filipovic M. Impact of loss of high-molecular-weight von Willebrand factor multimers on blood loss after aortic valve replacement. Br J Anaesth 2012; 108:754-62.
Feb 5, 2012Impact of loss of high-molecular-weight von Willebrand factor multimers on blood loss after aortic valve replacement
Feb 5, 2012Br J Anaesth 2012; 108:754-62
Bolliger D, Dell-Kuster S, Seeberger M D, Tanaka K A, Gregor M, Zenklusen U, Tsakiris D A, Filipovic Miodrag
Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy
Magenta L, Bernasconi E, Bucher H, Decosterd L, Cavassini M, Evison J, Vernazza P, Hirschel B, Flepp M, Hasse B, Young J, Richter W, Dell-Kuster S, the Swiss HIV Cohort Study (SHCS). Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy. AIDS Res Hum Retroviruses 2010
Nov 22, 2010Lipid and Lipoprotein Profile in HIV-Infected Patients Treated with Lopinavir/Ritonavir as a Component of the First Combination Antiretroviral Therapy
Nov 22, 2010AIDS Res Hum Retroviruses 2010
Magenta L, Bernasconi E, Bucher H C, Decosterd L A, Cavassini M, Evison J, Vernazza Pietro, Hirschel B, Flepp M, Hasse B, Young J, Richter W O, Dell-Kuster S, the Swiss HIV Cohort Study (SHCS)